KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
12.07
+0.06 (0.50%)
Oct 24, 2024, 4:00 PM EDT - Market closed
KalVista Pharmaceuticals Market Cap
KalVista Pharmaceuticals has a market cap or net worth of $521.61 million as of October 24, 2024. Its market cap has increased by 57.44% in one year.
Market Cap
521.61M
Enterprise Value
351.00M
1-Year Change
57.44%
Ranking
Category
Stock Price
$12.07
Market Cap Chart
Since April 9, 2015, KalVista Pharmaceuticals's market cap has increased from $129.30M to $521.61M, an increase of 303.41%. That is a compound annual growth rate of 15.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2024 | 519.00M | 22.61% |
| Dec 29, 2023 | 423.30M | 154.39% |
| Dec 30, 2022 | 166.40M | -48.59% |
| Dec 31, 2021 | 323.70M | -4.99% |
| Dec 31, 2020 | 340.70M | 7.27% |
| Dec 31, 2019 | 317.60M | -6.64% |
| Dec 31, 2018 | 340.20M | 223.69% |
| Dec 29, 2017 | 105.10M | 690.23% |
| Dec 30, 2016 | 13.30M | -86.04% |
| Dec 31, 2015 | 95.30M | -26.30% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Third Harmonic Bio | 550.30M |
| Surmodics | 546.14M |
| SI-BONE | 541.19M |
| Arcturus Therapeutics Holdings | 535.17M |
| Tectonic Therapeutic | 535.01M |
| Sharecare | 531.78M |
| Cartesian Therapeutics | 529.55M |
| UroGen Pharma | 525.16M |